Enzyme technologies: pluripotent players in discovering therapeutic agents
"This book highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. It provides in-depth reviews of recent developments in select topics on biosynthesis, biocatalysis, and chemical biology of enzymes. Broad coverage of enzymatic assays includes...
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Hoboken, NJ
Wiley
2014
|
Schriftenreihe: | Chemical biology of enzymes for biotechnology and pharmaceutical applications
2 |
Schlagworte: | |
Zusammenfassung: | "This book highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. It provides in-depth reviews of recent developments in select topics on biosynthesis, biocatalysis, and chemical biology of enzymes. Broad coverage of enzymatic assays includes emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in Life Sciences: metabolomics (including glycomics and lipidomics) and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era"-- |
Beschreibung: | Literaturangaben Weitere Ausgabe: Online version : Design of enzyme inhibitors |
Beschreibung: | XI, 344 S. Ill., graph. Darst. |
ISBN: | 9780470286265 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV042001156 | ||
003 | DE-604 | ||
005 | 20151027 | ||
007 | t | ||
008 | 140730s2014 ad|| |||| 00||| eng d | ||
010 | |a 2013013968 | ||
020 | |a 9780470286265 |c hardback |9 978-0-470-28626-5 | ||
035 | |a (OCoLC)890016528 | ||
035 | |a (DE-599)GBV742652696 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-29T |a DE-19 | ||
050 | 0 | |a QP601.5 | |
084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
245 | 1 | 0 | |a Enzyme technologies |b pluripotent players in discovering therapeutic agents |c ed. by Hsiu-Chiung Yang ... |
264 | 1 | |a Hoboken, NJ |b Wiley |c 2014 | |
300 | |a XI, 344 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Chemical biology of enzymes for biotechnology and pharmaceutical applications |v 2 | |
500 | |a Literaturangaben | ||
500 | |a Weitere Ausgabe: Online version : Design of enzyme inhibitors | ||
520 | 1 | |a "This book highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. It provides in-depth reviews of recent developments in select topics on biosynthesis, biocatalysis, and chemical biology of enzymes. Broad coverage of enzymatic assays includes emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in Life Sciences: metabolomics (including glycomics and lipidomics) and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era"-- | |
650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Enzyminhibitor |0 (DE-588)4152479-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
689 | 0 | 1 | |a Enzyminhibitor |0 (DE-588)4152479-2 |D s |
689 | 0 | 2 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Yang, Hsiu-Chiung |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-118-73989-1 |
830 | 0 | |a Chemical biology of enzymes for biotechnology and pharmaceutical applications |v 2 |w (DE-604)BV037242770 |9 2 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-027443194 |
Datensatz im Suchindex
_version_ | 1804152411323891712 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV042001156 |
callnumber-first | Q - Science |
callnumber-label | QP601 |
callnumber-raw | QP601.5 |
callnumber-search | QP601.5 |
callnumber-sort | QP 3601.5 |
callnumber-subject | QP - Physiology |
classification_rvk | VS 5350 |
ctrlnum | (OCoLC)890016528 (DE-599)GBV742652696 |
discipline | Chemie / Pharmazie |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02347nam a2200445 cb4500</leader><controlfield tag="001">BV042001156</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151027 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">140730s2014 ad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2013013968</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470286265</subfield><subfield code="c">hardback</subfield><subfield code="9">978-0-470-28626-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)890016528</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV742652696</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP601.5</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enzyme technologies</subfield><subfield code="b">pluripotent players in discovering therapeutic agents</subfield><subfield code="c">ed. by Hsiu-Chiung Yang ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 344 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Chemical biology of enzymes for biotechnology and pharmaceutical applications</subfield><subfield code="v">2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Weitere Ausgabe: Online version : Design of enzyme inhibitors</subfield></datafield><datafield tag="520" ind1="1" ind2=" "><subfield code="a">"This book highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. It provides in-depth reviews of recent developments in select topics on biosynthesis, biocatalysis, and chemical biology of enzymes. Broad coverage of enzymatic assays includes emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in Life Sciences: metabolomics (including glycomics and lipidomics) and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era"--</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Hsiu-Chiung</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-118-73989-1</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Chemical biology of enzymes for biotechnology and pharmaceutical applications</subfield><subfield code="v">2</subfield><subfield code="w">(DE-604)BV037242770</subfield><subfield code="9">2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027443194</subfield></datafield></record></collection> |
id | DE-604.BV042001156 |
illustrated | Illustrated |
indexdate | 2024-07-10T01:10:17Z |
institution | BVB |
isbn | 9780470286265 |
language | English |
lccn | 2013013968 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027443194 |
oclc_num | 890016528 |
open_access_boolean | |
owner | DE-29T DE-19 DE-BY-UBM |
owner_facet | DE-29T DE-19 DE-BY-UBM |
physical | XI, 344 S. Ill., graph. Darst. |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Wiley |
record_format | marc |
series | Chemical biology of enzymes for biotechnology and pharmaceutical applications |
series2 | Chemical biology of enzymes for biotechnology and pharmaceutical applications |
spelling | Enzyme technologies pluripotent players in discovering therapeutic agents ed. by Hsiu-Chiung Yang ... Hoboken, NJ Wiley 2014 XI, 344 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Chemical biology of enzymes for biotechnology and pharmaceutical applications 2 Literaturangaben Weitere Ausgabe: Online version : Design of enzyme inhibitors "This book highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. It provides in-depth reviews of recent developments in select topics on biosynthesis, biocatalysis, and chemical biology of enzymes. Broad coverage of enzymatic assays includes emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in Life Sciences: metabolomics (including glycomics and lipidomics) and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era"-- Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Enzyminhibitor (DE-588)4152479-2 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 s Enzyminhibitor (DE-588)4152479-2 s Arzneimitteldesign (DE-588)4278218-1 s DE-604 Yang, Hsiu-Chiung Sonstige oth Erscheint auch als Online-Ausgabe 978-1-118-73989-1 Chemical biology of enzymes for biotechnology and pharmaceutical applications 2 (DE-604)BV037242770 2 |
spellingShingle | Enzyme technologies pluripotent players in discovering therapeutic agents Chemical biology of enzymes for biotechnology and pharmaceutical applications Arzneimitteldesign (DE-588)4278218-1 gnd Enzyminhibitor (DE-588)4152479-2 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
subject_GND | (DE-588)4278218-1 (DE-588)4152479-2 (DE-588)4003120-2 |
title | Enzyme technologies pluripotent players in discovering therapeutic agents |
title_auth | Enzyme technologies pluripotent players in discovering therapeutic agents |
title_exact_search | Enzyme technologies pluripotent players in discovering therapeutic agents |
title_full | Enzyme technologies pluripotent players in discovering therapeutic agents ed. by Hsiu-Chiung Yang ... |
title_fullStr | Enzyme technologies pluripotent players in discovering therapeutic agents ed. by Hsiu-Chiung Yang ... |
title_full_unstemmed | Enzyme technologies pluripotent players in discovering therapeutic agents ed. by Hsiu-Chiung Yang ... |
title_short | Enzyme technologies |
title_sort | enzyme technologies pluripotent players in discovering therapeutic agents |
title_sub | pluripotent players in discovering therapeutic agents |
topic | Arzneimitteldesign (DE-588)4278218-1 gnd Enzyminhibitor (DE-588)4152479-2 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
topic_facet | Arzneimitteldesign Enzyminhibitor Arzneimittelforschung |
volume_link | (DE-604)BV037242770 |
work_keys_str_mv | AT yanghsiuchiung enzymetechnologiespluripotentplayersindiscoveringtherapeuticagents |